STAT3 Luciferase Reporter HEK293 Cell Line
The STAT3 Luciferase Reporter HEK293 Cell Line is a HEK293 cell lines expressing firefly luciferase driven by STAT3 response elements located upstream of a minimal TATA promoter. After activation by cytokines or growth factors, endogenous STAT3 binds to the response elements, inducing transcription of the luciferase reporter.
This cell line has been validated to respond to human interleukin-6 (IL-6) and human IL-27. Functional validation experiments showed that IL-6-induced luciferase activity was decreased by the JAK inhibitor CP 690,550 and by an anti-IL-6 Receptor neutralizing antibody.
Figure 1: Illustration of the mechanism behind reporter expression in the STAT3 Luciferase Reporter HEK293 Cell Line.
Created with BioRender.com
Interested in screening and profiling inhibitors, blocking antibodies, or activators of STAT3-mediated signaling without the need to purchase and license the cell line? Check out our Cell Signaling Pathway Screening.
This product has been cited 1 time.
Purchase of this cell line is for research purposes only; commercial use requires a separate license. View the full terms and conditions.
Materials Required for Cell Culture
Name | Ordering Information |
Thaw Medium 1 | BPS Bioscience #60187 |
Growth Medium 1N | BPS Bioscience #79801 |
Materials Required for Cellular Assay
Name | Ordering Information |
Human IL-6 | R&D Systems #206-IL |
JAK inhibitor CP 690,550 | Caymaan #11598 |
Anti-IL-6R anitbody | R&D Systems #MAB227 |
Assay Medium: Thaw Medium 1 | BPS Bioscience #60187 |
Growth Medium 1N | BPS Bioscience #79801 |
96-well tissue culture treated white clear-bottom assay plate | Corning #3610 |
ONE-Step™ luciferase assay system | BPS Bioscience #60690 |
Luminometer |
The cell line has been screened to confirm the absence of Mycoplasma species.
STAT3 (Signal Transducer and Activator of Transcription 3) is a transcription factor expressed in diverse cell types. STAT3 is phosphorylated by JAK (Janus Kinases) and gets translocated to the nucleus. While it was initially described as an acute phase response factor in the context of IL-6 signaling, STAT3 has since been identified as a downstream effector of many cytokines. STAT3-mediated IL-6 signaling in macrophages plays a role in their differentiation and proliferation. The JAK-STAT signaling pathway is involved in both cancer and autoimmune diseases and has been an attractive target for drug discovery in immunological diseases and cancer.
- Tian S., et al., 1994, Blood. 84(6):1760-1764.
- Zhong, Z., et al., 1994, Science. 264(5155):95-98.